OBSIDIAN THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 07 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99054596
- Mark type
- Stylized text
- Filed
- 24 Feb 2025
- Published for opposition
- 03 Jun 2025
- Attorney of record
- Olivia Maria Baratta
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the field of cell and gene therapies for the prevention and treatment of cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders.
Owner
- Obsidian Therapeutics, Inc., Cambridge, MA, US
- Obsidian Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Apr 2025 — EXAMINER'S AMENDMENT ENTERED
- 30 Apr 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 30 Apr 2025 — EXAMINERS AMENDMENT E-MAILED
- 30 Apr 2025 — EXAMINERS AMENDMENT -WRITTEN
- 21 Apr 2025 — ASSIGNED TO EXAMINER
- 24 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Feb 2025 — NEW APPLICATION ENTERED